T-cell cancer therapy holds promise, longer-term results await – Business Insider
Pulse Headlines |
T–cell cancer therapy holds promise, longer-term results await
Business Insider The new drug class, known as chimeric antigen receptor T–cell or CAR-T, involves a complicated process of extracting immune system T–cells from an individual patient, altering the cell DNA to sharpen their ability to spot and kill cancer cells, and … Novel leukemia treatment could be 1st US gene therapy FDA advisory committee recommends approval of T–cell 'living drug' to treat leukemia |
